Y Intercept (Hong Kong) LTD Xencor Inc Transaction History
Y Intercept (Hong Kong) LTD
- $3.75 Billion
- Q2 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Xencor Inc stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 95,745 shares of XNCR stock, worth $761,172. This represents 0.02% of its overall portfolio holdings.
Number of Shares
95,745
Previous 49,605
93.01%
Holding current value
$761,172
Previous $527,000
42.69%
% of portfolio
0.02%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding XNCR
# of Institutions
207Shares Held
78.7MCall Options Held
3.4KPut Options Held
1.9K-
Black Rock Inc. New York, NY11.1MShares$88.3 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.76MShares$77.6 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$62.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$48.9 Million5.14% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$31.2 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $475M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...